top of page
pexels-karola-g-7269618.jpg

Education Hub

Your central resource for evidence-based content in metabolic, cardiovascular, and renal medicine.

Core Topics
Landmark Trials

Educational summaries and commentary on pivotal clinical trials...
Coming Soon - New landmark trial videos will be added here shortly.

Landmark Trials

Heart failure, chronic kidney disease, atherosclerotic cardiovascular disease, lipid disorders, and other conditions in metabolic medicine.

00

Videos

Diabetes

Contemporary approaches to diabetes management, complications, and therapeutic advances.

00

Videos

Obesity

Weight management, metabolic health, and the evolving treatment landscape for obesity.

00

Videos

Cardiovascular and Kidney Conditions

Heart failure, chronic kidney disease, atherosclerotic cardiovascular disease, lipid disorders, and other conditions in metabolic medicine.

00

Videos

Number of videos found or no matching video

Heading 1

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Heading 1

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Heading 1

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Heading 1

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Heading 1

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Heading 1

I'm a paragraph. Click here to add your own text and edit me. It's easy.

I'm a paragraph. Click here to add your own text and edit me. It's easy.

Landmark Trials

Contemporary approaches to diabetes management, complications, and therapeutic advances.

Diabetes

Contemporary approaches to diabetes management, complications, and therapeutic advances.

Diabetes Under 40: Youth-Onset Diabetes Explained

3:54

In this @goggledocs video, Dr Amar Puttanna (Consultant Diabetologist) explains the increasingly common diagnosis of 'Youth-Onset Diabetes

Obesity

Weight management, metabolic health, and the evolving treatment landscape for obesity.

Muscle Matters: BELIEVE & COURAGE at ADA 2025

2:08

Dr Amar Puttanna covers two important ADA 2025 trials that zoom in on muscle preservation during GLP-1-driven weight loss.

Breaking News top-line results of the TRIUMPH-4 study (retatrutide)

2:20

Retatrutide delivers AGAIN!!! Experimental weight-loss treatment retatrutide tested in a phase 3 randomised control trial in Overweight/Obese adults with osteoarthritic knee pain.

Ozempic... The Good, the Bad and the Ugly

5:13

Dr Patrick Holmes from @GoggleDocs brings you a 2024 update on Semaglutide (aka Ozempic, Wegovy, Rybelsus)... from the latest scientific evidence to the growing pains.

Wegovy, Ozempic, Rybelsus: a 2-minute summary

2:07

Dr Patrick Holmes brings us up to speed with the molecule that has taken the world of diabetes and bariatric medicine by storm

Breaking News in Obesity: STEP1 (w Dr Sarah Davies)

18:42

Patrick and Amrit are joined by fellow Primary Care GP, Dr Sarah Davies, to discuss the recently published STEP 1 trial.

Cardiovascular and Kidney Conditions

Heart failure, chronic kidney disease, atherosclerotic cardiovascular disease, lipid disorders, and other conditions in metabolic medicine.

Cafés, canals and cardiology. ESC 2023 Preview

19:16

We preview the European Society of Cardiology's Annual Congress, in Amsterdam (25-28 August 2023). Focusing on the latest with Semaglutide in Heart Failure.

Breaking News: SGLT2i in ACUTE Heart Failure

3:44

This bite-sized video is a summary of the recent EMPULSE study, that investigated the use of Empagliflozin in people admitted to hospital with acute heart failure.

The Chronic Kidney Disease Playbook 2024

11:18

Chronic Kidney Disease affects up to 1 billion people worldwide. With complications including reduced life expectancy, cardiovascular disease and kidney failure.

bottom of page